Evaluation of SARS-CoV‑2 Main Protease Inhibitors Using a Novel Cell-Based Assay
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2022-02-01
|
Series: | ACS Central Science |
Online Access: | https://doi.org/10.1021/acscentsci.1c00910 |